Discover 1,147 paid clinical trials in New Haven, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,147
Featured
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
for
Migraine
Location: Stamford CT, Morristown NJ, Nashua NH, Philadelphia PA,
Sponsor: AbbVie
Sex: All
Age: 6 - 17
Code: NCT05125302
Phase3, Recruiting
Active & Responsive
A Study of the Pharmacokinetics, Biodistribution and Dosimetry of Granzyme-B Targeted [Cu-64]-Labeled PET Radiotracers in Adult Healthy Volunteers
for
Healthy Volunteer
Location: New Haven CT
Sponsor: Ratio Therapeutics, Inc.
Sex: All
Age: 18 - 60
Code: NCT07774650
Early_phase1, Recruiting
Active & Responsive
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
for
HIV Infections
Location: New Haven CT, Stony Brook NY, Newark NJ,
Sponsor: ViiV Healthcare
Sex: All
Age: 12+
Code: NCT07650916
Phase3, Recruiting
Active & Responsive
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
for
Parkinson Disease
Location: New Haven CT, New York NY, Boston MA, Philadelphia PA,
Sponsor: Michael J. Fox Foundation for Parkinson's Research
Sex: All
Age: 30+
Code: NCT04477785
Recruiting
Active & Responsive
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
for
Crohn's Disease
Location: New Haven CT, Port Jefferson NY, Great Neck NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 16 - 70+
Code: NCT06430801
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Aerobic Exercise and Obsessive-Compulsive Disorder Symptoms
for
Obsessive-Compulsive Disorder (OCD)
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18 - 64
Code: NCT07103902
Recruiting
Active & Responsive
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
for
Major Depressive Disorder (MDD), Depression in Adults,
Location: New Haven CT, New York NY, Toms River NJ, Boston MA,
Sponsor: Cybin IRL Limited
Sex: All
Age: 18 - 70+
Code: NCT06793397
Phase3, Recruiting
Active & Responsive
Speech Motor Learning and Retention (Aim 3)
for
Speech
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18 - 40
Code: NCT06492252
Recruiting
Active & Responsive
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
for
Chronic Migraine
Location: New Haven CT, Port Jefferson Station NY, Stamford CT,
Sponsor: Merz Therapeutics GmbH
Sex: All
Age: 18+
Code: NCT07018713
Phase3, Recruiting
Active & Responsive
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
for
Episodic Migraine
Location: New Haven CT, Port Jefferson Station NY, Stamford CT,
Sponsor: Merz Therapeutics GmbH
Sex: All
Age: 18+
Code: NCT07018700
Phase3, Recruiting
Active & Responsive
OssDsign® Spine Registry Study ("Propel")
for
Degenerative Disc Disease, Spinal Stenosis
Location: New Haven CT, New Britian CT, State College PA,
Sponsor: OssDsign
Sex: All
Age: 21+
Code: NCT05329129
Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
for
NASH - Nonalcoholic Steatohepatitis,
Location: New Haven CT, Manhasset NY, New York NY, Sparta NJ,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06528314
Phase3, Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
for
NASH With Fibrosis, MASH With Fibrosis
Location: New Haven CT, Manhasset NY, New York NY, Ridgewood NJ,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06215716
Phase3, Recruiting
Active & Responsive
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
for
Relapsed Refractory Multiple Myeloma
Location: New Haven CT, New York NY, Montreal, Toronto,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07391657
Phase3, Recruiting
Active & Responsive
Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD
for
Obsessive-Compulsive Disorder
Location: New Haven CT
Sponsor: Yale University
Sex: All
Age: 18 - 65
Code: NCT04131829
Phase1, Phase2, Recruiting
Active & Responsive
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation